The possible advantage of hybrid closed-loop therapy (i.e., artificial pancreas) over sensor-augmented pump therapy in very young children with type 1 diabetes is unclear. In this multicenter, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback